| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥240.0B | ¥236.3B | +1.6% |
| Operating Income | ¥11.8B | ¥12.2B | -3.3% |
| Ordinary Income | ¥11.3B | ¥13.4B | -15.6% |
| Net Income | ¥8.7B | ¥9.8B | -11.1% |
| ROE | 3.3% | 3.6% | - |
FY2025 Q3 results show revenue of 240.0B yen (YoY +1.6%), operating income of 11.8B yen (YoY -3.3%), ordinary income of 11.3B yen (YoY -15.6%), and net income of 8.7B yen (YoY -11.1%). The company achieved modest top-line growth but experienced profit contraction across all levels. The decline in ordinary income was more pronounced than operating income due to non-operating factors. Net income decreased by 1.1B yen from the prior year period, with EPS declining to 193.13 yen from 218.41 yen (YoY -11.6%). The company maintains a solid equity base of 267.9B yen against total assets of 487.5B yen, though profitability metrics have weakened from prior year levels.
Revenue increased 3.7B yen to 240.0B yen, representing growth of 1.6% year-over-year. This modest expansion reflects generally stable demand conditions across the company's geographic markets. Gross profit totaled 61.6B yen with a margin of 25.7%, indicating product-level profitability remains intact. However, SG&A expenses reached 49.8B yen, consuming 20.8% of revenue and constraining operating leverage. The 20.7B yen difference between gross profit and SG&A resulted in operating income of 11.8B yen, down 0.4B yen or 3.3% from the prior year. The operating margin compressed to 4.9% from 5.2% in the prior year period. Non-operating items contributed a net negative impact of approximately 0.5B yen, bringing ordinary income to 11.3B yen, a decline of 2.1B yen or 15.6% year-over-year. This larger decline at the ordinary income level reflects increased financial costs or foreign exchange headwinds that are separate from core operations. Profit before tax was 11.4B yen, closely aligned with ordinary income, indicating minimal extraordinary items at this stage. After tax effects, net income settled at 8.7B yen, down 1.1B yen or 11.1% from 9.8B yen in the prior year. The effective tax rate implied by the difference between profit before tax and net income was approximately 23.7%, consistent with normal corporate tax levels. The performance pattern reflects revenue up but profit down, driven by fixed cost burdens in SG&A and non-operating pressures that outpaced the modest revenue growth.
The company operates across three geographic segments: Asia generated revenue of 13.4B yen with operating income of 783M yen, representing an operating margin of 5.8%. Japan produced revenue of 12.5B yen with operating income of 272M yen, yielding a margin of 2.2%. Europe contributed revenue of 443M yen with operating income of 6M yen, for a margin of 1.3%. Asia is the largest segment by revenue and represents the core business, accounting for approximately 51% of total external segment sales. Asia also demonstrates the highest profitability margin among the three regions at 5.8%, more than double Japan's margin. Japan's lower margin of 2.2% suggests either higher cost structures or competitive pricing pressures in the domestic market. Europe remains a smaller operation with minimal profitability. Year-over-year changes show Japan revenue increased from 9.9B yen to 12.5B yen (up 26.3%), while Asia revenue declined slightly from 13.3B yen to 13.4B yen (up 0.9%), and Europe grew from 420M yen to 443M yen (up 5.4%). Operating income trends show Japan improved from 240M yen to 272M yen (up 13.3%), while Asia declined from 812M yen to 783M yen (down 3.6%), and Europe fell from 16M yen to 6M yen (down 64.4%). The segment adjustments primarily reflect intersegment transaction eliminations totaling 2.4B yen. The material margin differential between Asia at 5.8% and Japan at 2.2% warrants attention, as does the deterioration in Europe's already thin profitability.
[Profitability] ROE of 3.3% represents a significant decline from typical levels and falls well below the company's longer-term performance, reflecting both reduced net income and a lower equity base. Operating margin of 4.9% decreased from 5.2% in the prior year, indicating pressure on operating leverage despite stable gross margins. Net profit margin of 3.6% shows limited bottom-line conversion of revenue. [Cash Quality] Cash and deposits totaled 76.8B yen against current liabilities of 139.8B yen, providing coverage of 0.55x for total current obligations. Short-term debt coverage specifically against cash stands at approximately 1.22x considering short-term borrowings. [Investment Efficiency] Asset turnover of 0.492 indicates that the company generates approximately 49 sen in revenue for each yen of assets, below typical manufacturing sector norms. This reflects either capital-intensive operations or underutilized asset capacity. [Financial Health] Equity ratio of 55.0% indicates a moderately conservative capital structure with over half of assets financed by equity. Current ratio of 220.6% demonstrates strong short-term liquidity with current assets exceeding current liabilities by more than two times. Debt-to-equity ratio of 0.39 shows debt levels at 39% of equity, representing moderate leverage.
Operating cash flow of 6.3B yen represents 0.72x net income of 8.7B yen, indicating that earnings conversion to cash remains reasonable though below full parity. The 41.9% year-over-year decline in operating CF from prior year levels signals deteriorating working capital efficiency or timing differences in cash collections. Investing cash flow of negative 18.1B yen was entirely attributable to capital expenditures of the same amount, reflecting continued investment in property, plant and equipment. The CapEx intensity at 18.1B yen against depreciation and amortization of 10.3B yen produces a ratio of 1.76x, indicating the company is in a growth or renewal investment phase with capital spending significantly exceeding depreciation. Financing cash flow of positive 26.0B yen reflects net cash inflows from financing activities, offset partially by share repurchases of 6.8B yen. The positive financing CF suggests debt issuance or borrowing activities that more than offset the share buyback program. Free cash flow of negative 11.8B yen results from the combination of operating CF of 6.3B yen and investing CF of negative 18.1B yen, indicating that operating cash generation was insufficient to cover capital investment requirements. The negative FCF position necessitates external funding sources to maintain investment levels and shareholder returns.
Ordinary income of 11.3B yen versus operating income of 11.8B yen shows a negative non-operating contribution of approximately 0.5B yen, representing 0.2% of revenue. This modest non-operating burden suggests limited financial income was offset by interest expenses, foreign exchange impacts, or other financial costs. The composition of non-operating items is not explicitly detailed but the scale relative to operating income is not material. Operating cash flow of 6.3B yen compared to net income of 8.7B yen produces a ratio of 0.72x, indicating some divergence between accrual-based earnings and cash realization. This divergence warrants attention as it may reflect working capital build, timing effects in receivables or payables, or non-cash charges embedded in net income. The fact that operating CF trails net income suggests caution regarding earnings quality, though the gap is not extreme. With operating CF at 0.28x of EBITDA (calculated as operating income plus D&A of approximately 21.1B yen), cash conversion from EBITDA is notably weak, pointing to working capital absorption or other cash drags. The absence of material extraordinary items or impairment losses means reported earnings primarily reflect ongoing business performance, supporting fundamental earnings quality on that dimension.
Full-year guidance projects revenue of 324.0B yen (YoY -3.3%), operating income of 16.0B yen (YoY -16.7%), and ordinary income of 14.0B yen (YoY -27.2%). Against nine-month actuals of 240.0B yen revenue, 11.8B yen operating income, and 11.3B yen ordinary income, the progress rates stand at 74.1% for revenue, 73.8% for operating income, and 80.7% for ordinary income. At the Q3 stage, a standard progress rate would be 75%, meaning revenue and operating income are slightly behind pace while ordinary income is ahead of the typical quarterly cadence. The modest shortfall in revenue and operating income progress suggests Q4 would need to deliver 84.0B yen in revenue and 4.2B yen in operating income to meet targets, representing a significant sequential step-up in operating performance. The forecast revision implies a challenging fourth quarter with expected sequential deceleration in profitability. EPS forecast of 225.99 yen compares to the nine-month trailing EPS of 193.13 yen, suggesting an expected pickup in Q4 earnings. Annual dividend forecast of 90.00 yen has been established. The guidance assumes a recovery in operating leverage or cost management improvements in Q4 to achieve targets, though the year-over-year forecast decline across all metrics indicates ongoing structural headwinds.
Annual dividend forecast of 90.00 yen represents the company's planned shareholder distribution. Against the forecast EPS of 225.99 yen, this implies a payout ratio of 39.8%, which appears sustainable from an earnings coverage perspective. However, against the nine-month actual EPS of 193.13 yen, the 90.00 yen dividend would represent a 46.6% payout ratio, still within reasonable bounds but somewhat elevated if Q4 earnings do not materialize as forecast. Share repurchases of 6.8B yen were executed during the period, demonstrating active capital allocation toward shareholder returns beyond dividends. With net income of 8.7B yen for the nine-month period and buybacks of 6.8B yen plus implied dividends, total shareholder returns are substantial. The combined dividend commitment and buyback activity represent a total return ratio that exceeds 100% of nine-month net income, indicating an aggressive capital return policy. This level of shareholder distribution, while attractive to investors, raises questions about sustainability given the negative free cash flow of 11.8B yen and reliance on financing activities to fund the gap. The capital allocation strategy prioritizes immediate shareholder returns but requires careful monitoring against cash generation capacity and investment needs.
Revenue stagnation risk reflects the 1.6% year-over-year growth rate and full-year guidance projecting a 3.3% decline, indicating limited top-line momentum and potential demand headwinds. Geographic concentration in Asia and Japan exposes the company to regional economic cycles, with Asia contributing 51% of segment sales. Working capital deterioration risk is evidenced by Days Sales Outstanding extending to 173 days and inventory days at 82 days based on supplementary analysis, resulting in an extended cash conversion cycle that ties up capital and strains liquidity. Refinancing risk stems from short-term debt of 63.2B yen representing 60.2% of total debt obligations, creating maturity concentration and exposure to interest rate changes or credit availability at refinancing dates. High leverage relative to cash generation is quantified by Debt/EBITDA of 4.76x, well above prudent levels for the sector and indicating limited financial flexibility. Profitability pressure is demonstrated by operating margin compression to 4.9% and ROE of 3.3%, suggesting difficulty covering fixed costs and generating returns above the cost of capital. Capital allocation sustainability concerns arise from the combination of negative free cash flow of 11.8B yen, substantial share repurchases of 6.8B yen, and dividend commitments, which collectively exceed internally generated cash and necessitate external funding.
[Industry Position] (Reference - Proprietary Analysis) The company's profitability metrics fall below industry medians across key measures. ROE of 3.3% significantly underperforms the manufacturing industry median of 5.8% for 2025-Q3, placing the company in the lower quartile of peer profitability. Operating margin of 4.9% trails the industry median of 8.9%, indicating either higher cost structures or lower pricing power relative to sector norms. Net profit margin of 3.6% also lags the industry median of 6.5%, consistent with the operating margin underperformance and suggesting limited operating leverage. Financial health metrics present a mixed picture. The equity ratio of 55.0% sits below the industry median of 63.8%, indicating relatively higher leverage than sector peers. However, the current ratio of 2.21x compares favorably to the industry median of 2.87x, though still suggests adequate short-term liquidity. Efficiency measures show asset turnover of 0.492 below the industry median of 0.56, indicating the company generates less revenue per unit of assets than typical manufacturing peers. Working capital metrics are notably weak, with operating working capital turnover at approximately 298 days well above the industry median of 111.5 days, signaling inefficient use of working capital. Receivables turnover at 173 days substantially exceeds the industry median of 85.4 days, and inventory turnover at 82 days is below the median of 112.3 days but combined with receivables creates excessive cash cycle length. Revenue growth of 1.6% aligns with the industry median of 2.8%, suggesting comparable but modest expansion. The company's CapEx/D&A ratio of 1.76x exceeds the industry median of 1.44x, indicating more aggressive investment relative to depreciation than peers. Net Debt/EBITDA of 4.76x is significantly elevated compared to the industry median of negative 1.11x, highlighting the company's relatively high debt burden. Overall, the company ranks below median on profitability, efficiency, and leverage metrics, with particular weakness in working capital management and financial leverage. (Industry: Manufacturing, N=105 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
The earnings data reveals three significant characteristics for investors to consider. First, profitability is under structural pressure with operating margin compressing to 4.9% and ROE declining to 3.3%, both well below historical norms and industry medians, driven by fixed SG&A costs at 20.8% of revenue that limit operating leverage despite stable gross margins of 25.7%. Second, cash generation capacity has deteriorated materially with operating cash flow declining 41.9% year-over-year to 6.3B yen, producing negative free cash flow of 11.8B yen after capital expenditures of 18.1B yen that exceed depreciation by 76%, indicating the business currently consumes more cash than it generates. Third, the financial structure shows elevated leverage with Debt/EBITDA at 4.76x and 60% of debt maturing short-term, while simultaneously executing aggressive shareholder returns through 6.8B yen in buybacks and dividend commitments that together exceed reported nine-month earnings, creating a capital allocation dynamic that depends on external financing rather than internal cash generation. These trends suggest the company is navigating a transitional phase requiring operational improvements in working capital efficiency and cost management to restore profitability and self-sustaining cash flows.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.